Non-identical genes and their application in improved molecular adjuvants
AssigneeAdProTech Limited
InventorsVivienne Frances Cox, Richard Anthony Godwin Smith, Pamela Jane Elizabeth Rowling
Life of this patent
Estimating the term…
Loading patent…
AssigneeAdProTech Limited
InventorsVivienne Frances Cox, Richard Anthony Godwin Smith, Pamela Jane Elizabeth Rowling
Estimating the term…
The invention provides a linear concatamer of at least two non-identical DNA sequences which, by virtue of third base redundancy of the genetic code of the codons, each encode the same polypeptide of at least 30 amino acids; wherein the concatamer comprises or consists of a nucleic acid sequence which codes for an oligomer of said polypeptides in a continuous reading frame. A single invariant cysteine codon may be added to one DNA sequence to encode a polypeptide derivative with a unique unpaired cysteine. The concatamer may be fused to one or more sequences encoding one or more antigens. The DNA sequences in the concatamer may encode the compliment C3 fragment C3d or an analogue thereof. The invention also provides an expression vector comprising the concatamer nucleic acid sequence and regulatory or other sequences for expression of any oligomeric polypeptide encoded thereby, as well as a host cell comprising the expression vector. The invention can also provide a method of including a immune response to an antigen in the human or animal by administering a concatamer or administering a vector. Thus the invention can provide a pharmaceutical composition in the form of a DNA vaccine.
A nucleic acid sequence encoding at least one autonomously folding polypeptide domain or at least one immunogenic polypeptide having greater than 30 amino acids, wherein the sequence comprises a linear concatamer of at least two non-identical DNA sequences, wherein the non-identical DNA sequences each encode the same amino acid sequence of said autonomously folding polypeptide domain or immunogenic polypeptide that is a ligand of complement receptor type 2 (CR2, CD21), and wherein the concatamer comprises a sequence encoding an oligomer of the autonomously folding polypeptide domain or immunogenic polypeptide in a continuous reading frame.
Dependencies are inferred from the claim text.